Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273897 · ClinicalTrials.gov registry record · Phase 2
Electrical Polarization of the Brain in Corticobasal Syndrome
A Phase 2 study of Corticobasal Syndrome, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00273897: Completed Phase 2 study of Corticobasal Syndrome, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00273897 is a Phase 2 study of Corticobasal Syndrome that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 20 participants, below the 304-participant average among 6 other Corticobasal Syndrome trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00273897, a Phase 2 study of Corticobasal Syndrome, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether DC electrical polarization of the brain can temporarily improve hand function in patients with corticobasal syndrome (CBS). In this degenerative disorder of the brain, nerve cells die over time, causing a progressive decline in the patient's ability to use their hands. This is always worse on one side. Other symptoms include arm or leg stiffness, tremor, gait unsteadiness, and speech difficulty. Some patients also have some decline in thinking ability, such as loss of skilled activities, poor problem solving abilities poor concentration, problems with language, and forgetfulness,. DC electrical polarization of the brain involves placing sponge electrodes on the head and passing a very weak current between them. DC polarization can temporarily improve the ability of healthy people to make word lists and may improve symptoms in some brain diseases. Patients 40 and older with CBS who have participated in NINDS protocol 02-N-0001 ("Testing a Model of the Representational Knowledge Stored in the Human Prefrontal Cortex") may be eligible for this study. In protocol 02-N-0001, participants provide a medical history, undergo a neurological examination, PET scanning and MRI, and complete tests, such as sitting in front of a computer monitor and press a key to indicate a decision about what appears on the screen (for example, whether a statement is accurate) and answering questions from a test examiner. For the current protocol, participants have three 2-hour testing sessions at the NIH Clinical Center, scheduled at least one day apart. In each session, sponge electrodes are placed on the head so that they affect different areas of the brain. Two areas are involved with hand movement; the third does not. The electrodes are dampened with water and attached to the sides of the patient's head. When the current is turned on, the patient may feel some tingling. The current is on for 40 minutes, but can be reduced or stopped early if the tingling beco
Conditions Studied
Interventions
- DEVICE Phoresor II
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12-30 |
| Phase | Phase 2 |
What the finished NCT00273897 record still lists
NCT00273897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 304-participant average among 6 other Corticobasal Syndrome trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Corticobasal Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Phoresor II is the first listed.
NCT00273897 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00273897 about?
NCT00273897 is a clinical study titled "Electrical Polarization of the Brain in Corticobasal Syndrome". This study will test whether DC electrical polarization of the brain can temporarily improve hand function in patients with corticobasal syndrome (CBS). In this degenerative disorder of the brain, nerve cells die over time, causing a progressive decline in the patient's ability to use their hands. T...
What is the current status of trial NCT00273897?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2005-12-30.
What conditions does trial NCT00273897 study?
This clinical trial studies the following conditions: Corticobasal Syndrome.
What interventions are being tested in trial NCT00273897?
The interventions under investigation include: Phoresor II (DEVICE).
Who is sponsoring clinical trial NCT00273897?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00273897 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corticobasal Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
RECRUITING · NA
-
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
RECRUITING · NA
-
The CurePSP Genetics Program
RECRUITING
-
Imaging Studies in Corticobasal Syndrome
RECRUITING
-
Music and Brain Stimulation for Upper Extremity Performance in Patients With Corticobasal Syndrome
ACTIVE NOT RECRUITING · NA
-
In-Home Care for Patients With PSP and Related Disorders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI